Atika Capital Management LLC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 68 filers reported holding OCULAR THERAPEUTIX INC in Q2 2018. The put-call ratio across all filers is 0.35 and the average weighting 1.1%.

Quarter-by-quarter ownership
Atika Capital Management LLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q1 2018$1,432,000220,0000.49%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q2 2018
NameSharesValueWeighting ↓
SUMMER ROAD LLC 5,944,761$23,898,000100.00%
Opaleye Management Inc. 5,974,800$24,019,00010.83%
DELTEC ASSET MANAGEMENT LLC 2,069,313$8,319,0001.95%
Kamunting Street Capital Management, L.P. 275,506$1,108,0001.50%
Altium Capital Management LP 695,000$2,794,0001.12%
Endurant Capital Management LP 760,228$3,056,0001.07%
EMERALD ADVISERS, LLC 1,465,702$5,892,0000.30%
MSD Partners, L.P. 1,016,302$4,086,0000.25%
EMERALD MUTUAL FUND ADVISERS TRUST 1,044,732$4,200,0000.24%
NOTTINGHAM ADVISORS, INC. 194,266$781,0000.11%
View complete list of OCULAR THERAPEUTIX INC shareholders